These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30763550)

  • 1. Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk assessment.
    Clewell RA; Thompson CM; Clewell HJ
    Chem Biol Interact; 2019 Mar; 301():112-127. PubMed ID: 30763550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
    Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
    Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation.
    Roberts RA; Crump KS; Lutz WK; Wiegand HJ; Williams GM; Harrison PT; Purchase IF
    Arch Toxicol; 2001 Nov; 75(9):507-12. PubMed ID: 11760810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment of chemical carcinogens and thresholds.
    Neumann HG
    Crit Rev Toxicol; 2009; 39(6):449-61. PubMed ID: 19545196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
    Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
    Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.
    Bevan RJ; Harrison PTC
    Regul Toxicol Pharmacol; 2017 Aug; 88():291-302. PubMed ID: 28119000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of thresholds on the risk assessment of carcinogens in food.
    Pratt I; Barlow S; Kleiner J; Larsen JC
    Mutat Res; 2009 Aug; 678(2):113-7. PubMed ID: 19442758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the evidence for thresholds for DNA-Reactive and epigenetic experimental chemical carcinogens.
    Kobets T; Williams GM
    Chem Biol Interact; 2019 Mar; 301():88-111. PubMed ID: 30763546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches.
    Guyton KZ; Kyle AD; Aubrecht J; Cogliano VJ; Eastmond DA; Jackson M; Keshava N; Sandy MS; Sonawane B; Zhang L; Waters MD; Smith MT
    Mutat Res; 2009; 681(2-3):230-240. PubMed ID: 19010444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear-No-Threshold Default Assumptions for Noncancer and Nongenotoxic Cancer Risks: A Mathematical and Biological Critique.
    Bogen KT
    Risk Anal; 2016 Mar; 36(3):589-604. PubMed ID: 26249816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.
    Melnick RL; Kohn MC; Portier CJ
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay.
    Lutz WK; Kopp-Schneider A
    Toxicol Sci; 1999 May; 49(1):110-5. PubMed ID: 10367348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds for carcinogens.
    Calabrese EJ; Priest ND; Kozumbo WJ
    Chem Biol Interact; 2021 May; 341():109464. PubMed ID: 33823170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.